Hypoxemia increases serum interleukin-6 in humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Hypoxemia increases serum interleukin-6 in humans. / Klausen, T; Olsen, Niels Vidiendal; Poulsen, T D; Richalet, J P; Pedersen, B K.

I: European Journal of Applied Physiology and Occupational Physiology, Bind 76, Nr. 5, 1997, s. 480-2.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Klausen, T, Olsen, NV, Poulsen, TD, Richalet, JP & Pedersen, BK 1997, 'Hypoxemia increases serum interleukin-6 in humans', European Journal of Applied Physiology and Occupational Physiology, bind 76, nr. 5, s. 480-2.

APA

Klausen, T., Olsen, N. V., Poulsen, T. D., Richalet, J. P., & Pedersen, B. K. (1997). Hypoxemia increases serum interleukin-6 in humans. European Journal of Applied Physiology and Occupational Physiology, 76(5), 480-2.

Vancouver

Klausen T, Olsen NV, Poulsen TD, Richalet JP, Pedersen BK. Hypoxemia increases serum interleukin-6 in humans. European Journal of Applied Physiology and Occupational Physiology. 1997;76(5):480-2.

Author

Klausen, T ; Olsen, Niels Vidiendal ; Poulsen, T D ; Richalet, J P ; Pedersen, B K. / Hypoxemia increases serum interleukin-6 in humans. I: European Journal of Applied Physiology and Occupational Physiology. 1997 ; Bind 76, Nr. 5. s. 480-2.

Bibtex

@article{2f23383bc93b49338079116a689394ee,
title = "Hypoxemia increases serum interleukin-6 in humans",
abstract = "Serum concentrations of interleukin (IL) 1 beta, IL-1 receptor antagonist (IL-1ra), IL-6, tumor necrosis factor (TNF) alpha, and C-reactive protein (CRP) were determined in ten healthy men at sea level and during four days of altitude hypoxia (4350m above sea level). The mean (SD) arterial blood oxygen saturations were 78.6 (7.3)%, 82.4 (4.9)%, and 83.4 (5.3)% in the first, second, and third days at altitude, respectively. A symptom score of acute mountain sickness (AMS) revealed that the subjects had mostly light symptoms of AMS. Mean serum IL-6 increased from 1.36 (1.04) pg x ml(-1) at sea level to 3.10 (1.65), 4.71 (2.81), and 3,54 (2.17) pg x ml(-1) during the first three days at altitude, and to 9.96 (8.90) pg x ml(-1) on the fourth day at altitude (ANOVA p = 0.002). No changes occurred in serum concentrations of IL-1 beta, IL-1ra, TNF alpha, or CRP. The serum IL-6 were related to SaO2, (r = -0.45, p = 0.003), but not to heart rates or AMS scores. In conclusion, human serum concentrations of IL-6 increased during altitude hypoxia whereas the other proinflammatory cytokines remained unchanged. The major role of IL-6 during altitude hypoxia seem not to be mediation of inflammation, instead, the role of IL-6 could be to stimulate the erythropoiesis at altitude.",
keywords = "Adult, Altitude Sickness, Anoxia, C-Reactive Protein, Humans, Interleukin 1 Receptor Antagonist Protein, Interleukin-1, Interleukin-6, Male, Oxygen, Receptors, Interleukin-1, Sialoglycoproteins, Tumor Necrosis Factor-alpha",
author = "T Klausen and Olsen, {Niels Vidiendal} and Poulsen, {T D} and Richalet, {J P} and Pedersen, {B K}",
year = "1997",
language = "English",
volume = "76",
pages = "480--2",
journal = "European Journal of Applied Physiology and Occupational Physiology",
issn = "0301-5548",
publisher = "Springer Verlag",
number = "5",

}

RIS

TY - JOUR

T1 - Hypoxemia increases serum interleukin-6 in humans

AU - Klausen, T

AU - Olsen, Niels Vidiendal

AU - Poulsen, T D

AU - Richalet, J P

AU - Pedersen, B K

PY - 1997

Y1 - 1997

N2 - Serum concentrations of interleukin (IL) 1 beta, IL-1 receptor antagonist (IL-1ra), IL-6, tumor necrosis factor (TNF) alpha, and C-reactive protein (CRP) were determined in ten healthy men at sea level and during four days of altitude hypoxia (4350m above sea level). The mean (SD) arterial blood oxygen saturations were 78.6 (7.3)%, 82.4 (4.9)%, and 83.4 (5.3)% in the first, second, and third days at altitude, respectively. A symptom score of acute mountain sickness (AMS) revealed that the subjects had mostly light symptoms of AMS. Mean serum IL-6 increased from 1.36 (1.04) pg x ml(-1) at sea level to 3.10 (1.65), 4.71 (2.81), and 3,54 (2.17) pg x ml(-1) during the first three days at altitude, and to 9.96 (8.90) pg x ml(-1) on the fourth day at altitude (ANOVA p = 0.002). No changes occurred in serum concentrations of IL-1 beta, IL-1ra, TNF alpha, or CRP. The serum IL-6 were related to SaO2, (r = -0.45, p = 0.003), but not to heart rates or AMS scores. In conclusion, human serum concentrations of IL-6 increased during altitude hypoxia whereas the other proinflammatory cytokines remained unchanged. The major role of IL-6 during altitude hypoxia seem not to be mediation of inflammation, instead, the role of IL-6 could be to stimulate the erythropoiesis at altitude.

AB - Serum concentrations of interleukin (IL) 1 beta, IL-1 receptor antagonist (IL-1ra), IL-6, tumor necrosis factor (TNF) alpha, and C-reactive protein (CRP) were determined in ten healthy men at sea level and during four days of altitude hypoxia (4350m above sea level). The mean (SD) arterial blood oxygen saturations were 78.6 (7.3)%, 82.4 (4.9)%, and 83.4 (5.3)% in the first, second, and third days at altitude, respectively. A symptom score of acute mountain sickness (AMS) revealed that the subjects had mostly light symptoms of AMS. Mean serum IL-6 increased from 1.36 (1.04) pg x ml(-1) at sea level to 3.10 (1.65), 4.71 (2.81), and 3,54 (2.17) pg x ml(-1) during the first three days at altitude, and to 9.96 (8.90) pg x ml(-1) on the fourth day at altitude (ANOVA p = 0.002). No changes occurred in serum concentrations of IL-1 beta, IL-1ra, TNF alpha, or CRP. The serum IL-6 were related to SaO2, (r = -0.45, p = 0.003), but not to heart rates or AMS scores. In conclusion, human serum concentrations of IL-6 increased during altitude hypoxia whereas the other proinflammatory cytokines remained unchanged. The major role of IL-6 during altitude hypoxia seem not to be mediation of inflammation, instead, the role of IL-6 could be to stimulate the erythropoiesis at altitude.

KW - Adult

KW - Altitude Sickness

KW - Anoxia

KW - C-Reactive Protein

KW - Humans

KW - Interleukin 1 Receptor Antagonist Protein

KW - Interleukin-1

KW - Interleukin-6

KW - Male

KW - Oxygen

KW - Receptors, Interleukin-1

KW - Sialoglycoproteins

KW - Tumor Necrosis Factor-alpha

M3 - Journal article

C2 - 9367289

VL - 76

SP - 480

EP - 482

JO - European Journal of Applied Physiology and Occupational Physiology

JF - European Journal of Applied Physiology and Occupational Physiology

SN - 0301-5548

IS - 5

ER -

ID: 47240447